PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma.

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q36561681

about

Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment.Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma.Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.PD-1/PD-L1 biology and immunotherapy in HPV-positive oral cancers.STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.Cancer and inflammation.Redirecting the focus of cancer immunotherapy to premalignant conditions.B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model.NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.Role of IL-23 signaling in the progression of premalignant oral lesions to cancer.

P2860

Q33771631-4E30BB69-718D-4A13-90E5-A4AE6AF4698F Q33832752-B418DC42-23D2-4BF5-AC4F-6E0F0389263E Q33884361-07554B6D-698F-4180-AA6F-8A675A6DAA49 Q37012605-214489E4-D5B2-4B47-A22B-4F56FA5EE5E6 Q37079094-CF6B9F10-98E9-4B24-9234-14D3F008F617 Q37664203-514875D1-7D77-451D-B04F-15749A0AA938 Q38638841-346CBDCC-FD9D-4B41-8D57-4A3900A25B4D Q38700564-1F73D79A-776C-473C-9326-0E592B8B8544 Q38742013-252E0395-99B5-4F11-9549-0C954D78352E Q39036378-956D0D8C-0CEA-4835-8BDC-459077F5CE62 Q39107022-DF1E8D20-21A1-49A3-8A31-F88F6D329757 Q39627356-9FD24A09-118D-46F8-BB9C-B517C0FCB5AD Q40208391-05C1D9FE-57BC-4B49-8D14-AAA55442A513 Q40256299-1192DC06-2EDE-4901-AF55-3C95BFFE0F44 Q40446457-0B5AD6EA-9FFA-4523-8908-96E92221A7FF Q41140931-93A2DEFB-C428-4311-A7F9-7D89F3F4BE0C Q41595173-E5C176A9-11D4-49F2-BB86-2B6EB9E5AA82 Q41997200-21E407A4-86E8-438C-9829-D0A7E08FF23A Q47199775-37F87D83-E37F-46D6-85CD-76A4DE0E900A Q48220238-9C0FCE72-4136-42D5-BC8D-2B09ADA1690D Q52316792-02759A82-DACD-4974-ACA4-A1CD09504B52 Q55174561-58703073-5504-4F3E-BC66-C5B4C3D99BF2 Q55265890-3E72A445-04E1-4C27-A16F-B0C2B2D75B40

P2860

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q36561681

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

PD-1 blockade attenuates immun ...... neck squamous cell carcinoma.

@ast

PD-1 blockade attenuates immun ...... neck squamous cell carcinoma.

@en

type

label

PD-1 blockade attenuates immun ...... neck squamous cell carcinoma.

@ast

PD-1 blockade attenuates immun ...... neck squamous cell carcinoma.

@en

prefLabel

PD-1 blockade attenuates immun ...... neck squamous cell carcinoma.

@ast

PD-1 blockade attenuates immun ...... neck squamous cell carcinoma.

@en

P1433

Q36561681-817D12F4-BFDB-4CB4-8A67-162A9FE58E30

P1476

Q36561681-6DEE7A3A-C237-4BC8-B210-9CA0D7948B89

P2093

Q36561681-13C00F33-C0D7-445E-B9FB-4524499C7A63

Q36561681-27D1728E-3765-465E-A1C0-2B69BC4B3B6C

Q36561681-292ED21E-AF03-4E2F-843B-8E6DE2AE9EEE

Q36561681-6AAF87CC-A7FC-4BC0-9FB5-632789B6BB7F

Q36561681-6E0492BE-654F-44FB-BF5E-DFD0ECDC0474

Q36561681-6F098847-8422-4254-84F2-8E30FE6D43C0

Q36561681-A444B14D-27A0-44D6-A9FE-D511A4301C5E

P2860

Q36561681-05D73F32-C432-4C3F-BC97-EE4E02B107AB

Q36561681-0BF52378-C9C4-46F4-94D1-F0E181333826

Q36561681-12E859EE-B98B-466E-86D0-693F3D5C9B4E

Q36561681-209EE5CC-AED8-4878-8447-2FD2B3EA8AC4

Q36561681-21D31D23-BA05-411E-BE25-9BEF0A633ECB

Q36561681-24B1F6B7-15E7-40E3-A7FC-99F7705F4DF5

Q36561681-2626E11B-70AF-462D-B2ED-A6ACFB0312B1

Q36561681-2A7A0B22-6206-404C-ADA0-E340BF4932F6

Q36561681-2B64827B-D30A-4C3F-8780-3C02ABDD7478

Q36561681-2ED04F79-C7BB-40A5-9BF8-E4A8F4AB9CA5

P304

Q36561681-EBFA6987-68EE-43CA-AE51-B8088A9C11B8

P31

Q36561681-8778F6B7-1ABE-4C4C-BA55-EF37E4772FD7

P356

Q36561681-3903F689-6B0A-4B01-B4EC-B6518979373A

P407

Q36561681-AC28EE8E-5298-4D48-BBF5-C9D17703CDD6

P433

Q36561681-B537095F-C230-4591-930A-7344B2958E9A

P478

Q36561681-445DF8AD-21E7-43E3-A809-9C122849C11D

P50

Q36561681-30C83958-8710-447B-9C09-7244B41498A0

P577

Q36561681-AF3A77D3-85E5-4678-9FE6-5546C8FC32D8

P5875

Q36561681-D5BC15B2-4144-40C3-BE07-D65DEA3B196C

P698

Q36561681-370B51F3-BA6A-4EBA-8981-DDD943158ADD

P932

Q36561681-EBE81B03-7462-4940-ABDA-85349C5EA3B3

P356

ONCOTARGET.5955

P1433

P1476

PD-1 blockade attenuates immun ...... neck squamous cell carcinoma.

@en

P2093

Ashok B Kulkarni

http://www.w3.org/2001/XMLSchema#string

Cong-Fa Huang

http://www.w3.org/2001/XMLSchema#string

Guang-Tao Yu

http://www.w3.org/2001/XMLSchema#string

Lin-Lin Bu

http://www.w3.org/2001/XMLSchema#string

Wan-Jun Chen

http://www.w3.org/2001/XMLSchema#string

Wen-Feng Zhang

http://www.w3.org/2001/XMLSchema#string

Zhi-Jun Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Cluster analysis and display of genome-wide expression patterns

Human papillomavirus and survival of patients with oropharyngeal cancer.

Myeloid-derived suppressor cells as regulators of the immune system

Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Cancer immunotherapy comes of age

P304

42067-42080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5955

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

J. Silvio Gutkind

P577

2015-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284165548

http://www.w3.org/2001/XMLSchema#string

P698

26573233

http://www.w3.org/2001/XMLSchema#string

P932

4747210

http://www.w3.org/2001/XMLSchema#string